REgulatory T Cell Therapy to Achieve Immunosuppression REduction
REgulatory T Cell Therapy to Achieve Immunosuppression REduction
Recruiting · NCT06552169 · Registry updated 2026-04-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| REgulatory T Cell Therapy to Achieve Immunosuppression REduction | Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, chronic renal failure syndrome, kidney disorder, kidney failure, urinary system disorder | Recruiting | Phase 2 | 2026-04-27 | NCT06552169 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Singulera Therapeutics Inc. | 1 |
| Taiwan Bio Therapeutics Inc. | 1 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Chang Gung Medical Foundation Hospital | Taoyuan | Taiwan | 1 |
| Mayo Clinic in Arizona | Phoenix | United States | 14 |
| Mayo Clinic in Minnesota | Rochester | United States | 5 |
| National Cheng Kung University Hospital | Tainan | Taiwan | 135 |
| National Taiwan University Hospital | Taipei | Taiwan | 19 |
| Northwestern Memorial Hospital | Chicago | United States | 129 |
| Taichung Veterans General Hospital | Taichung | Taiwan | 33 |